Articles tagged "Kidney transplantation"

2016 American Transplant Congress
Three-Year Outcome After HSCT with Subsequent KT from the Same Haploidentical Donor without Immunosuppression.
C. Schwarz,¹ A. Lawitschka,² G. Böhmig,³ E. Dauber,⁴ H. Greinix,⁵ N. Kozakowski,⁶ F. Mühlbacher,¹ G. Berlakovich,¹ T. Wekerle.⁷
¹Dept. of Surgery, Div. of Transplantation, Medeical University of Vienna, Vienna, Austria; ²St. Anna Children's Hospital, Vienna, Austria; ³Dept. of Internal Medicine, Division of Nephrology, Medical University of Vienna, Vienna, Austria; ⁴Dept. of Transfusion Medicine, Medical University of Vienna, Vienna, Austria; ⁵Dept of Internal Medicine, Div of Hematology, Medical University of Graz, Graz, Austria; ⁶Dept. of Clinical Pathology, Medical University of Vienna, Vienna, Austria; ⁷Section of Transplantation Immunology, Dept. of Surgery, Medical University of Vienna, Vienna, Austria.
Allogeneic hematopoietic stem cell transplantation (HSCT) can lead to donor-specific tolerance. Patients reported in the literature that underwent kidney transplantation (KT) after a previous HSCT…
2016 American Transplant Congress
Acute Rejection by Belatacept (Bela) Dosing Frequency: Results from a Phase II Study of Kidney Transplant Recipients.
F. Vincenti,¹ G. Blancho,² A. Durrbach,³ G. Grannas,⁴ J. Grinyó,⁵ U. Meier-Kriesche,⁶ M. Polinsky,⁶ H. Zhao,⁶ C. Larsen.⁷
¹UCSF, San Francisco, CA; ²University Hospital of Nantes, Nantes, France; ³University Hôpital of Bicêtre, Le Kremlin-Bicêtre, France; ⁴Medizinische Hochschule Hannover, Hannover, Germany; ⁵University Hospital of Bellvitge, Bellvitge, Spain; ⁶Bristol-Myers Squibb, Lawrenceville, NJ; ⁷Emory University Transplant Center, Atlanta, GA.
Background: At 1 year post transplant in IM103-100 (NCT00035555), bela-treated patients had similar acute rejection (AR) rates and significantly improved renal function vs cyclosporine A…
2016 American Transplant Congress
The Impact of Donor Procurement Characteristics in Contemporary Live Donor Pediatric Renal Transplantation Outcomes: An Analysis of 282 Cases.
Z. Ahmed,¹ R. Uwechue,¹ P. Chandak,¹ J. Stojanovic,² N. Kessaris,¹ N. Mamode.¹
¹Abdominal Transplant Unit, Guy's Hospital, London, United Kingdom; ²Paediatric Nephrology, Evelina Children's Hospital, London, United Kingdom.
Previous registry analyses have reported inferior graft survival rates when using laparoscopically procured organs and those with the greatest size mismatches between donor and recipient.…
2016 American Transplant Congress
Cost-Effectiveness of Machine Perfusion Use After Long Cold Ischemic Time in a Kidney Transplantation Program.
A. Matos, D. Malheiros, S. Morgado, L. Requiao-Moura, M. Borrelli, M. Nogueira, M. Durao, E. Tonato, A. Pacheco-Silva.
Renal Transplantation Unit, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
In Brazil the incidence of DGF is very high (60-70%) mainly due to an inadequate care of the donors and long cold ischemia time. This…
2016 American Transplant Congress
Comparison of Efficacy of Different Regimens for Treating Recurrent IgA Nephropathy After Kidney Transplantation.
G. Chen, C. Wang, L. Chen, J. Qiu, C. Wang, J. Fei, S. Deng, J. Li, G. Huang, Q. Fu.
Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Background Recurrent IgA nephropathy is a common complication after kidney transplantation. How to treat recipients with recurrent IgA nephropathy is still controversial. There are two…
2016 American Transplant Congress
Is There a Link Between Proteinuria and Increased FGF-23 Levels in Renal Transplant Patients.
E. Tutal,¹ S. Sezer,¹ Z. Bal,¹ B. Demirci,¹ M. Haberal.²
¹Nephrology, Baskent University Faculty of Medicine, Ankara, Turkey; ²General Surgery, Baskent University Faculty of Medicine, Ankara, Turkey.
Purpose: Fibroblast growth factor 23 (FGF23) has emerged as a risk factor for cardiovascular disease and mortality in renal transplant (RT) recipients. Post transplantation proteinuria…
2016 American Transplant Congress
Effect of Inflammation on Concentration of Intracellular Tacrolimus.
E. Bae,¹ S. Yang,² S. Han,¹ J.-Y. Park,¹ H. Lee,¹ Y. Kim.¹
¹Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; ²Kidney Research Institute, Seoul National University, Seoul, Republic of Korea.
Background: The use of calcineurin inhibitors improved the outcome for transplant recipients. However, acute rejection (AR) and infection remained still an unsolved problem. We evaluated…
2016 American Transplant Congress
Delays in the Live Kidney Donor Evaluation Process.
J. Leanza, K. Kumar, J. Tonascia, E. King, A. Massie, D. Segev.
JHU, Baltimore.
One of the barriers to live kidney donation (LKD) is successful completion of the evaluation process. While it is known that many potential donors (PDs)…
2016 American Transplant Congress
Surveillance Renal Allograft Biopsies Prognosticate Graft Function.
J. Thompson, D. Taber, P. Baliga, K. Chavin, T. Srinivas.
MUSC, Charleston, SC.
Background: Surveillance biopsy of the renal allograft provides a window into the health of the allograft and could allow prognostication of function by affording better…
2016 American Transplant Congress
“Day 2 Discharge” After Kidney Transplantation: Complications, Health Care Utilization, and Long-Term Clinical Outcomes.
A. Mathur, N. Katariya, A. Welu, J. Chang, R. Heilman, A. Singer, H. Khamash, H. Chakkera, W. Hewitt, D. Haakinson, M. Maningo-Salinas, E. Oakley, A. Moss, K. Reddy.
Transplant Center, Mayo Clinic, Phoenix.
Background: Reducing kidney transplant length of stay is a priority for many stakeholders. We aimed to determine whether very early discharge – on or before…